Monday’s trading session is showcasing significant movements among stocks across various market cap categories. Mega-cap stocks like Tesla Motors (NASDAQ:) and Nvidia Corp (NASDAQ:) are experiencing gains, while large-cap stocks such as Palantir Technologies Inc (NYSE:) are also seeing notable upticks. Here’s a rundown of some of the most impactful stock movers, from the highest to the smallest market caps.
Mega-Cap Movers (Market Cap $200B+):
- Tesla Motors (TSLA): +3.72%; YTD return: -15.19%
- Nvidia Corp (NVDA): +1.74%; YTD return: 107.67%
- United Health Group (UNH): -0.95%; YTD return: 14.3%
- Amazon Com Inc (NASDAQ:): +1.55%; YTD return: 12.8%
Large-Cap Stock Movers (Market Cap $10B-$200B):
- Palantir Technologies Inc (PLTR): +12.07%; YTD return: 76.65%; added to
- MicroStrategy Inc (MSTR): +5.09%; YTD return: 80.96%; rallies
- Moderna (NASDAQ:); Recent Company News: Moderna’s Canadian Manufacturing Facility Receives Drug Establishment License From Health Canada: +6.55%; YTD return: -26.71%
- Coinbase Global (NASDAQ:): +3.49%; YTD return: -15.28%; Bitcoin rallies
- Erie Indemnity Co (ERIE): +3.44%; YTD return: 52.76%; added to S&P 500
- DocuSign Inc (NASDAQ:): -4.04%; YTD return: -0.44%
- Arm (ARM): +4.22%; YTD return: 56.08%; Apple (NASDAQ:) new AI iPhone to use Arm tech
Mid-Cap Stock Movers (Market Cap $2B-$10B):
- Summit Therapeutics PLC (NASDAQ:): +69.93%; YTD return: 370.11%
- ADMA Biologics Inc (NASDAQ:): +14.08%; YTD return: 259.73%
- Impinj Inc (PI): +10.34%; YTD return: 74.09%
- Compass (COMP): +10.93%; YTD return: 37.23%
- Inspire Medical Systems Inc (NYSE:): +9.01%; YTD return: -3.22%
- NantKwest (NASDAQ:); Recent Company News: ImmunityBio reports extended survival in NSCLC therapy trial: +8.58%; YTD return: -32.67%
- Clear Secure (YOU): +6.97%; YTD return: 41.86%
Small-Cap Stock Movers (Market Cap $300M-$2B):
- Relay Therapeutics Inc (RLAY); Recent Company News: Relay Therapeutics reports progress in breast cancer treatment: +46.8%; YTD return: -43.32%
- Emerald Expositions Events Inc (NYSE:): +17.16%; YTD return: -10.11%
- Terns Pharmaceuticals (TERN); Recent Company News: Terns Pharmaceuticals reports promising Phase 1 obesity drug trial: +21.64%; YTD return: 20.34%
- Global Partner Acquisition II (SDST): +17.68%; YTD return: -37.4%
- Pacific Bioscienc (PACB): +11.49%; YTD return: -83.89%
- Longview Acquisition (BFLY); Recent Company News: Fierce Names Butterfly Network as a Fierce 50 Honoree of 2024: +13.72%; YTD return: 51.85%
For real-time, market-moving news, join Investing Pro.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
Read the full article here
